Cosmos Health Stock Performance
| COSM Stock | USD 0.52 0.02 3.74% |
The firm shows a Beta (market volatility) of 1.92, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cosmos Health will likely underperform. At this point, Cosmos Health has a negative expected return of -0.85%. Please make sure to confirm Cosmos Health's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Cosmos Health performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Cosmos Health has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Last Split Factor 1:10 | Dividend Date 2017-11-21 | Last Split Date 2017-11-21 |
1 | Cosmos Holdings Non-GAAP EPS of -0.02, revenue of 17.11M | 11/17/2025 |
2 | Acquisition by Grigorios Siokas of 61614 shares of Cosmos Health at 0.6492 subject to Rule 16b-3 | 11/19/2025 |
3 | Acquisition by Grigorios Siokas of 55732 shares of Cosmos Health at 0.628 subject to Rule 16b-3 | 11/25/2025 |
4 | Acquisition by Grigorios Siokas of 76360 shares of Cosmos Health at 0.6417 subject to Rule 16b-3 | 11/28/2025 |
5 | Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform 300M Treasury and Tokenize IP Assets | 12/03/2025 |
6 | Acquisition by Grigorios Siokas of 168472 shares of Cosmos Health at 0.4155 subject to Rule 16b-3 | 12/15/2025 |
7 | Cosmos Health receives Nasdaq notice for minimum bid price deficiency - Investing.com | 12/18/2025 |
8 | Siokas buys Cosmos Health shares worth 43,000 - Investing.com | 12/22/2025 |
9 | Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units | 01/05/2026 |
10 | Acquisition by Grigorios Siokas of 133953 shares of Cosmos Health at 0.5375 subject to Rule 16b-3 | 01/06/2026 |
11 | Acquisition by Grigorios Siokas of 156190 shares of Cosmos Health at 0.5186 subject to Rule 16b-3 | 01/08/2026 |
12 | Acquisition by Grigorios Siokas of 113185 shares of Cosmos Health at 0.5036 subject to Rule 16b-3 | 01/12/2026 |
13 | Cosmos Health Announces Initiation of Analyst Coverage with 4.50 Valuation by Zacks Small-Cap Research | 01/14/2026 |
14 | Acquisition by Grigorios Siokas of 353321 shares of Cosmos Health at 0.4953 subject to Rule 16b-3 | 01/20/2026 |
15 | Cosmos Health CEO Siokas buys 175k in shares - Investing.com | 01/21/2026 |
| Begin Period Cash Flow | 3.8 M | |
| Total Cashflows From Investing Activities | -798.3 K |
Cosmos Health Relative Risk vs. Return Landscape
If you would invest 94.00 in Cosmos Health on October 28, 2025 and sell it today you would lose (44.00) from holding Cosmos Health or give up 46.81% of portfolio value over 90 days. Cosmos Health is currently does not generate positive expected returns and assumes 6.0663% risk (volatility on return distribution) over the 90 days horizon. In different words, 54% of stocks are less volatile than Cosmos, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Cosmos Health Target Price Odds to finish over Current Price
The tendency of Cosmos Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.52 | 90 days | 0.52 | about 74.12 |
Based on a normal probability distribution, the odds of Cosmos Health to move above the current price in 90 days from now is about 74.12 (This Cosmos Health probability density function shows the probability of Cosmos Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.92 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Cosmos Health will likely underperform. Additionally Cosmos Health has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Cosmos Health Price Density |
| Price |
Predictive Modules for Cosmos Health
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cosmos Health. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cosmos Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cosmos Health Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Cosmos Health is not an exception. The market had few large corrections towards the Cosmos Health's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cosmos Health, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cosmos Health within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.07 | |
β | Beta against Dow Jones | 1.92 | |
σ | Overall volatility | 0.17 | |
Ir | Information ratio | -0.17 |
Cosmos Health Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cosmos Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cosmos Health can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Cosmos Health generated a negative expected return over the last 90 days | |
| Cosmos Health has high historical volatility and very poor performance | |
| Cosmos Health has some characteristics of a very speculative penny stock | |
| Cosmos Health has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 54.43 M. Net Loss for the year was (16.18 M) with profit before overhead, payroll, taxes, and interest of 6.82 M. | |
| Cosmos Health currently holds about 322.37 K in cash with (7.72 M) of positive cash flow from operations. | |
| Cosmos Health has a poor financial position based on the latest SEC disclosures | |
| Roughly 27.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Cosmos Health CEO Siokas buys 175k in shares - Investing.com |
Cosmos Health Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cosmos Stock often depends not only on the future outlook of the current and potential Cosmos Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cosmos Health's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 19.1 M | |
| Cash And Short Term Investments | 336.3 K |
Cosmos Health Fundamentals Growth
Cosmos Stock prices reflect investors' perceptions of the future prospects and financial health of Cosmos Health, and Cosmos Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cosmos Stock performance.
| Return On Equity | -0.64 | ||||
| Return On Asset | -0.13 | ||||
| Profit Margin | (0.31) % | ||||
| Operating Margin | (0.11) % | ||||
| Current Valuation | 38.75 M | ||||
| Shares Outstanding | 37.35 M | ||||
| Price To Earning | 2.41 X | ||||
| Price To Book | 0.80 X | ||||
| Price To Sales | 0.31 X | ||||
| Revenue | 54.43 M | ||||
| Gross Profit | 6.82 M | ||||
| EBITDA | (13.92 M) | ||||
| Net Income | (16.18 M) | ||||
| Cash And Equivalents | 322.37 K | ||||
| Total Debt | 11.82 M | ||||
| Debt To Equity | 4.79 % | ||||
| Current Ratio | 1.05 X | ||||
| Book Value Per Share | 0.73 X | ||||
| Cash Flow From Operations | (7.72 M) | ||||
| Earnings Per Share | (0.77) X | ||||
| Market Capitalization | 16.65 M | ||||
| Total Asset | 54.31 M | ||||
| Retained Earnings | (114.02 M) | ||||
| Working Capital | (296.19 K) | ||||
| Current Asset | 6.37 M | ||||
| Current Liabilities | 1.61 M | ||||
About Cosmos Health Performance
By examining Cosmos Health's fundamental ratios, stakeholders can obtain critical insights into Cosmos Health's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Cosmos Health is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 36.48 | 46.89 | |
| Return On Tangible Assets | (0.31) | (0.33) | |
| Return On Capital Employed | (0.63) | (0.59) | |
| Return On Assets | (0.27) | (0.28) | |
| Return On Equity | (0.76) | (0.72) |
Things to note about Cosmos Health performance evaluation
Checking the ongoing alerts about Cosmos Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cosmos Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cosmos Health generated a negative expected return over the last 90 days | |
| Cosmos Health has high historical volatility and very poor performance | |
| Cosmos Health has some characteristics of a very speculative penny stock | |
| Cosmos Health has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 54.43 M. Net Loss for the year was (16.18 M) with profit before overhead, payroll, taxes, and interest of 6.82 M. | |
| Cosmos Health currently holds about 322.37 K in cash with (7.72 M) of positive cash flow from operations. | |
| Cosmos Health has a poor financial position based on the latest SEC disclosures | |
| Roughly 27.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Cosmos Health CEO Siokas buys 175k in shares - Investing.com |
- Analyzing Cosmos Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cosmos Health's stock is overvalued or undervalued compared to its peers.
- Examining Cosmos Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cosmos Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cosmos Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cosmos Health's stock. These opinions can provide insight into Cosmos Health's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cosmos Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cosmos Health. If investors know Cosmos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cosmos Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.77) | Revenue Per Share | Quarterly Revenue Growth 0.379 | Return On Assets | Return On Equity |
The market value of Cosmos Health is measured differently than its book value, which is the value of Cosmos that is recorded on the company's balance sheet. Investors also form their own opinion of Cosmos Health's value that differs from its market value or its book value, called intrinsic value, which is Cosmos Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cosmos Health's market value can be influenced by many factors that don't directly affect Cosmos Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cosmos Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cosmos Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cosmos Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.